For research use only. Not for therapeutic Use.
Brain Derived Basic Fibroblast Growth Factor (1-24) (FGF basic 1-24) is a synthetic peptide, shows anti-bacterial and anti-HBV activities. Brain Derived Basic Fibroblast Growth Factor (1-24) can be used in infection disease and immune disease research[1].
Brain Derived Basic Fibroblast Growth Factor (1-24) (10 μg/mL; 12 h) inhibits the growth of Streptococcus pneumoniae[1].
Brain Derived Basic Fibroblast Growth Factor (1-24) (10 μg/mL; 6 d) inhibits HBV replication of HepG2-2.2.15 cells[1].
Brain Derived Basic Fibroblast Growth Factor (1-24) (10 μg/mL; 22 h) inhibits the migration of human endothelial cell[1].
Catalog Number | I042540 |
CAS Number | 211362-85-5 |
Molecular Formula | C118H173N31O33 |
Purity | ≥95% |
Reference | [1]. Dorian Bevec, et al. Use of bfgf 1-24 and optionally (arg 8) vasopressin to treat eg s. pneumoniae infection. WO2009039980A2. |